Newest Covid variant causing ‘razor blade throat.' What to know
NB.1.8.1, which is also known as or 'Nimbus,' is now nearly the most prevalent omicron lineage tracked by the Centers for Disease Control and Prevention.
As the name implies, infection may lead to an incredibly painful sore throat, according to experts.
Other symptoms, though, are more typical of a Covid infection, including fever, chills, cough, shortness of breath, and the loss of taste or smell.
'A 'razor blade throat' is a very descriptive term describing severe sore throat pain — as if their throat is covered with razor blades — (like) with various viral infections,' Dr. Aaron Glatt, chair of the department of medicine and chief of infectious diseases at Mount Sinai South Nassau in New York, told TODAY.com.
'While not specific to Covid-19, this expression has been used to describe sore throat symptoms in some patients with the most recent Covid-19 variant,' he said.
But although the new omicron variant may result in a painful infection, experts say that it does not appear to be more severe than others.
'Every time you get a new strain, it always is a little bit more transmissible than what came before it,' Dr. Peter Chin-Hong, a UCSF infectious disease specialist, told SFGATE.
'Just like a pop song is more catchy when it rises to the top of the charts. And this particular one, Nimbus, is not just proportionally higher right now in California, the speed at which it's rising in the charts is also high … but it's not more severe.'
Just how virulent it is remains a topic of discussion.
'What sets NB.1.8.1 apart is how quickly it spreads,' explains Dr. Magdalena Sobieszczyk, chief of the Division of Infectious Diseases at NewYork-Presbyterian/Columbia University Irving Medical Center, said in a statement.
'It has a genetic advantage: mutations that make it easy for it to bind to receptors on human cells. The mutations could allow NB.1.8.1 to spread faster and, therefore, infect more people.'
The World Health Organization has designated Nimbus as a 'variant under monitoring,' and considers the public health risk low globally.
Current vaccines are expected to remain effective. But the longevity of the availability of Covid vaccines in the U.S. remains murky.
Health and Human Services Secretary Robert F. Kennedy, Jr., said last month that shots are no longer recommended for healthy children and pregnant women. He has also removed members of the Centers for Disease Control and Prevention's vaccine advisory panel and replaced them with people who have been skeptical of Covid vaccines and mandates.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
30 minutes ago
- Daily Mail
Shaquille O'Neal opens up on painkiller addiction that he hid from his family throughout NBA career
Shaquille O'Neal has has opened up on his addiction to painkillers which he hid from his family throughout his NBA career. The former Los Angeles Laker has been open about his use of the drug during his days on the court and discussed the topic again during a podcast appearance. O'Neal was a guest on the 'Armchair Expert' podcast hosted by Dax Shepard, who said to the four-time NBA champion: 'You had to be on pain pills to play. You had to'. The 53-year-old confirmed that he did, before Shepard continued: 'You were playing through so many injuries. Again, back to this thing where I'm suspicious that for you to admit you have any weakness would be too painful. 'You're just keeping it all in, right? You're just playing through everything. You have stuff that's going on and yeah, you had to be on pain pills. 'How did that not grab you? Or did it grab you a little bit? Have you ever been scared about any of that addiction wise?' O'Neal responded: 'I have a question. Is addicting for the chemical effect or are you just taking it? Because I was having a heated discussion with my doctors like, 'You were addicted.' But I didn't feel high. So I didn't know that was addiction. 'I don't think I was suffering mentally. I think if I had a knack, I would take it because I don't want to feel that knack because we need this game.' The conversation then turned to whether he hid his drug abuse. O'Neal revealed: 'The trainers knew. I mean, I'm not telling my wife or my kids or my boys.' O'Neal previously opened up about the addiction during an interview with GQ back in 2022. Back then, he said: 'When you play, you go to the doctor to get checked and a physical, right? But I ain't played in 11, years so if I'm not playing, what would I go to the doctor for, right? 'So when I went back to the doctor there was some stuff I never even knew. They give you those certain words: 'Hey man, you got sleep apnea. Sleep apnea can cause hypertension or strokes, you could die.' I said, 'What?' 'You could die.' So now I've got to sleep with a sleep machine.' 'Then, 'All those painkillers you were taking, bro? Your kidneys are kind of weak. No more painkillers.' I was dependent upon painkillers — not addicted. 'Certain days when I couldn't move, I just popped one or two, just to get me going. But I'm off that now.' Meanwhile, O'Neal made headlines last month after he reignited his feud with Rudy Gobert after admitting he 'f***ing hates' the Minnesota Timberwolves star. O'Neal and Gobert are not the best of friends after trading insults through the media for a number of years, with the NBA Hall of Famer brutally calling his fellow center 'the worst player of all time' last year. And now Shaq has taken aim at his bitter nemesis once again after doubling down on the claim that he doesn't deserve his $250million Minnesota contract. 'I f***ing hate Rudy Gobert,' O'Neal said on the latest episode of his 'Big Podcast'.
The Independent
an hour ago
- The Independent
The future of cancer treatment is ‘personalized' mRNA vaccines. Experts fear RFK research cuts will jeopardize that
Scientists have discovered the ability to 'personalize' cancer treatments using cutting-edge genetic technology - but experts fear that Health and Human Services Secretary Robert F. Kennedy, Jr.'s, recent funding cuts will have 'a profound chilling effect' on U.S. progress in this area of medicine. The new mRNA vaccines are specifically engineered to address the genetic differences of each patient with stomach cancer, according to Japanese researchers in a study published Tuesday, which makes them more effective than standard treatments. But, vaccine experts told The Independent that $500 million cuts to mRNA development at Emory University, Pfizer, and other institutions in flu, Covid and infectious disease vaccines could be devastating to progress in the U.S. 'Secretary Kennedy's decision to cancel $500 million in contracts and spread lies about the safety and protection offered by mRNA vaccines will have a profound chilling effect on innovative medical research,' Dr. Jennifer Nuzzo, director of the Pandemic Center at the Brown University School of Public Health, told The Independent in an email. 'mRNA vaccines hold tremendous promise to not only protect us from some of the worst infections, but also from devastating diseases like cancer,' she added. 'Rather than look forward at the promise of life-saving cures, the secretary would prefer that we look backwards towards the dark ages when these diseases ravaged us.' mRNA vaccines work differently from traditional vaccines, which inject a weakened virus into the body to trigger an immune response. Instead, mRNA vaccines teach the body's cells to make small and harmless pieces of virus that trigger the same response. The only mRNA vaccines currently available are Covid vaccines, but cancer vaccines work by getting the body to attack the disease. The new vaccines, described in the Japanese study, harness this technology and advance it by targeting unique spots on tumors. Last week, Kennedy said he would wind down some mRNA vaccine development, saying that the Department of Health and Human Services was 'shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.' Kennedy, a longtime vaccine skeptic, has spread misinformation that mRNA Covid vaccines are deadly and that vaccines 'poisoned' American children, despite decades of public research and countless government assessments that have deemed them safe. HHS's mRNA cuts have not impacted cancer vaccine research, which is underway at the Texas-based Baylor College of Medicine and other medical institutions, Dr. Peter Hotez, a vaccine scientist and pediatrician at the school, said. Baylor had announced it was testing the effectiveness of personalized mRNA vaccines in 2023. But, funding cuts and denouncements of the tech can affect the field more broadly. 'Therefore it's important that the federal government and the Department of Health and Human Services reverse their position on mRNA vaccines and throw their support behind this technology,' Hotez said. Dr. Paul Offit, a vaccine expert at Children's Hospital of Philadelphia, told The Independent that mRNA research in the fight against cancer is 'critical.' 'It's tragic that we have wrapped this up into politics, which will only hurt our ability to move forward,' he said. HHS told The Independent said that recent $500m cuts to Covid, flu and infectious disease mRNA vaccines would not impact other medical research in the area. 'Technologies that were funded during the emergency phase but failed to meet current scientific standards will be phased out in favor of evidence-based, ethically grounded solutions – like whole-virus vaccines and novel platforms. Other uses of mRNA technology within the department are not impacted by this announcement,' Press Secretary Emily Hilliard said in an email. The new study, from Kindai University in Osaka, explains that the vaccine targets the unique biological signatures of each patient's tumor cells. 'NeoAgs, derived from individual genetic alterations in each cancer patient, serve as unique immunological targets on tumor cells and represent the key to personalized immunotherapy,' Kindai University's Professor Kazuhiro Kakimi said in a statement. The mRNA vaccine helps the body create more cancer-attacking white blood cells and resulted in tumors shrinking or disappearing. When used with an unnamed cancer drug, it had a heightened effect on tackling the tumor, the study found. The Japanese researchers said the vaccine was particularly effective on peritoneal metastasis, the condition when stomach cancer spreads to the lining of the abdomen. It is one of the most common forms of reoccurring cancer following surgery for stomach cancer. Stomach cancer is one of the leading causes of cancer deaths in the world. The U.S. is estimated to see 30,300 new cases of stomach cancer and 10,780 deaths this year, according to the American Cancer Society. It disproportionally affects men, with more than 2,000 more deaths than women.
Daily Mail
an hour ago
- Daily Mail
Vaccine on RFK Jr's chopping block could protect against one of the deadliest cancers
Experimental mRNA vaccines shrouded in controversy may protect against one of America's deadliest cancers, a new study suggests. Researchers across the country tested a personalized mRNA vaccine on people with pancreatic cancer who had already had surgery and still had traces of the disease remaining. Pancreatic cancer is one of the hardest forms of the disease to treat, with a five-year survival rate of just 12 percent. And most cases are diagnosed after the disease has ravaged other organs, as it symptoms are usually mistaken for more benign issues. The vaccine uses mRNA technology, which uses RNA to tell cells how to make proteins and induce an immune reaction, to targets mutations of the KRAS gene. KRAS mutations are thought to be responsible for nine in 10 pancreatic cancers and nearly half of colon cancers. The researchers, from major institutions like Memorial Sloan Kettering Cancer Center in New York City and the University of California, Los Angeles (UCLA), found about 85 percent of participants had an immune response to the vaccine. And two-thirds had enough of a response to stave off lingering cancer cells. Participants also lived more than twice as long after getting the vaccine than pancreatic cancer patients on average. Dr Zev Wainberg, trial leader and co-director of the UCLA gastrointestinal oncology program, told NBC News: 'That far exceeds the rates with resectable cancers.' Resectable cancers are those than can be removed with surgery. mRNA technology, which is also used in Covid vaccines, has been hailed a 'game-changer' in the cancer space, leading to a mountain of new trials testing if it can be used in vaccines. In one research paper out of Penn State College of Medicine, the scientists note: 'mRNA vaccines are an attractive and powerful immunotherapeutic platform against cancer because of their high potency, specificity, versatility, rapid and large-scale development capability, low-cost manufacturing potential, and safety.' Despite expert consensus and scientific evidence, however, Health Secretary Robert F Kennedy Jr, a longtime vaccine skeptic, has repeatedly cast doubt on the safety and efficacy of mRNA vaccines. Earlier this month he announced the Department of Health and Human Services (HHS) would cancel nearly $500million in contracts for new vaccine development, including those for mRNA shots. Pancreatic cancer affects roughly 67,000 Americans every year and kills about 52,000. Along with colon cancer, it is also increasingly affecting young people. More than half the time, the disease is first spotted after it has already reached stage three or four due to its vague symptoms. These include abdominal pain, weight loss, back pain, jaundice and floating or clay-colored stools. This leads patients to assume their symptoms are from more benign causes like irritable bowel syndrome (IBS). By the time it reaches stage four, the five-year survival rate is just three percent, making it virtually incurable. It's unclear exactly what causes pancreatic cancer, but smoking, obesity and diabetes are thought to increase the risk by inducing harmful inflammation that causes cells to divide and become mutated more easily. In the new phase I trial, published Monday in the journal Nature Medicine, doctors recruited 20 people with pancreatic cancer and five with colorectal cancer. All participants had a KRAS mutation and had undergone standard treatment, which usually includes chemotherapy and surgery, to shrink and remove most of their tumors. Blood tests revealed the patients had traces of cells left behind, known as microscopic residual disease, which can travel elsewhere in the body and grow into tumors. After surgery, each participant received up to six doses of the vaccine, called ELI-002 2P, and 13 also received booster shots. The team found 85 percent, or 21 out of 25 participants, showed an immune response to the vaccine, and about 66 percent had enough of an immune response to stave off lingering cancer cells. And in nearly 70 percent of participants, the vaccine triggered an immune response not just to KRAS mutations but to other tumor cell targets not in the vaccine. The phase 1 trial also showed people with pancreatic cancer survived for an average of 29 months and lived recurrence-free for 15 months. The average survival length for patients with stage four pancreatic cancer, which is when most are diagnosed, is usually just six months to a year. The team is now running a phase 2 trial to test the vaccine's durability and compare if it is more effective than the current standard of care, which involves monitoring for disease recurrence.
